Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 62 results for "ajanta pharma"

A Positive Reaction to RBI's Status Quo
Equitymaster.com

A Firm Start to the Week

Posted by Equitymaster Indian Indices rallied smartly amid strong buying activity, thus ending on a positive note. At the closing bell, the BSE Sensex closed higher by 120 points, the NSE Nifty finished higher by 35 points. The S&P BSE Midcap & the S&P BSE ... Equitymaster.com, 2 days ago
Firm Start to the Week Equitymaster.com, 3 weeks ago
A Strong Start to the Week Equitymaster.com, 1 month ago

42 images for ajanta pharma

Business Standard India, 1 week ago
Moneycontrol.com, 1 month ago
Financial Express, 1 month ago
Yahoo! Singapore, 1 month ago
Minyanville, 1 month ago
Moneycontrol.com, 1 month ago
Yahoo! Singapore, 1 month ago
International Business Times, 1 month ago
Business Standard India, 1 month ago
Livemint.com, 1 month ago
Money Control

Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

This new approval is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 26 Abbreviated New Drug Application (ANDA) of which it has final approvals for 12 ANDAs; tentative approvals for 1 ANDA; and ...
 India PRwire3 weeks ago Ajanta Pharma shares move up over 3% on USFDA nod for drug  Business Standard1 month ago Ajanta Pharma hits new high on USFDA approval; shares up 3%  Money Control1 month ago Ajanta Pharma gets final approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension  Business Standard1 month ago
[x]  

Ajanta Pharma, Crompton, LT Finance bullish plays: Prakash Gaba

Nifty has support at 8600 and resistance at 8746 while Bank Nifty has support at 18800and resistance at 19050, according to Prakash Gaba of prakashgaba.com.
 Money Control3 weeks ago Support for Nifty at 8240; 8K Miles bullish play: Prakash Gaba  Money Control1 month ago

Top buzzers: Ajanta Pharma, Blue Dart Express

Shares of Blue Dart Express declined 3 percent intraday as its first quarter (April-June) net profit was down 1.4 percent at Rs 44.1 crore, while total income was up 0.7 percent at Rs 621.4 crore, against corresponding quarter of last fiscal.
 Money Control1 month ago
Money Control

Ajanta Pharma Q1 net up 39% at Rs 119.55 crore

Shares of the comapny were trading 3.40% up at Rs 1,707.75 ascrip on BSE
 Business Standard1 month ago Ajanta Pharma Q1 net up 39 pc at Rs 119.55 cr  Money Control1 month ago

Results to watch out for! Dr.Reddy's Lab, Ambuja Cements, Maruti Suzuki in focus

The results which are expected today are Dr.Reddy's Laboratories, Ambuja Cements, Maruti Suzuki India, ACC, Ajanta Pharma, IDFC Bank, Bharti Infratel.
 India Infoline1 month ago Tuesday results: ACC, Maruti, Dr Reddy’s Labs  Business Line1 month ago
Money Control

Ajanta Pharma launches acid reflux drug in US

Ajanta Pharma has launched genericomeprazole and sodium bicarbonate capsules, used in thetreatment of acid reflux and ulcers, in the US market afterreceiving final approval from the country's health regulator.
 Money Control1 month ago Ajanta Pharma promoters to invest in restaurant biz  The Financial Chronicle2 months ago
[x]  
Money Control

Ajanta Pharma shines after USFDA nod

In total, Ajanta has 26 Abbreviated New Drug Application (ANDA) of which it has final approvals for 12 ANDAs; tentative approvals for 1 ANDA; and 13 ANDAs are under review with US FDA.
 India Infoline1 month ago Ajanta Pharma launches anti-dementia drug in US  Money Control2 months ago Ajanta Pharma shares up 2% on launch of anti-dementia drug in US  Money Control2 months ago Ajanta Pharma gains after launching anti-dementia drug in US  India Infoline2 months ago
[x]  

Chart Check: ACC, HDFC Bank, L&T, Ajanta Pharma

Here are a few trading ideas from Chandan Taparia of Anand Rathi Chandan Taparia | Mumbai June 16, 2016 Last Updated at 06:11 IST Here are a few trading ideas from Chandan Taparia of Anand Rathi: ACC: BUY STOP LOSS: Rs 1,505 TARGET: Rs 1,603 The stock formed ...
 Business Standard2 months ago
India Infoline

Ajanta Pharma drops despite Rs.100 cr investment plan

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline2 months ago Ajanta Pharma ends 1% lower despite drug launched in US  India Infoline2 months ago Ajanta Pharma launches Memantine Hydrochloride tablets in US market  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ajanta pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less